Search results
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo News· 2 months agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo News· 2 months agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo News· 3 months agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo News· 3 months agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding
Zacks via Yahoo News· 4 months agoModerna (MRNA) posts data on three experimental vaccines and intends to advance them to late-stage...
Canadian TikToker says sun made her lip filler swell up. Here's what an expert says
Yahoo Canada Style· 1 year agoA TikToker with lip filler shared a video of her swollen lips during a trip to Italy....
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo News· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo News· 1 year agoWe expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...
Novavax (NVAX) Starts A New Study on COVID-Flu Combo Jab
Zacks via Yahoo News· 2 years agoNovavax (NVAX) initiates a mid-stage study evaluating its COVID-19-Influenza combination and...
Novavax (NVAX) Q3 Earnings Miss, Lowers '22 Sales Outlook
Zacks via Yahoo News· 2 years agoNovavax, Inc. NVAX incurred a loss of $2.15 per share for third-quarter 2022, which missed the Zacks...